Exact Mass: 317.10274300000003

Exact Mass Matches: 317.10274300000003

Found 64 metabolites which its exact mass value is equals to given mass value 317.10274300000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N2-Monodes-methylnizatidine

[(E)-1-(methylamino)-2-nitroethenyl]({2-[({2-[(methylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl})amine

C11H19N5O2S2 (317.0980114)


N2-Monodes-methylnizatidine is a metabolite of nizatidine. Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). It was developed by Eli Lilly and is marketed under the brand names Tazac and Axid. (Wikipedia)

   

N-2-Mdmn

Methyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulphanyl]methyl}-1,3-thiazol-2-yl)methyl]amine

C11H19N5O2S2 (317.0980114)


   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6 (317.1025082)


   

2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile

2-{2-[4-(3,5-Dimethyl-1H-pyrazol-1-yl)phenyl]hydrazono}-2-(methylsulfonyl)acetonitrile

C14H15N5O2S (317.094641)


   

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

Methyl 2-cyano-3-(2-morpholino-5-nitrophenyl)acrylate

C15H15N3O5 (317.101166)


   
   

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

C13H19NO8 (317.1110614)


   
   

Oxyphenisatin

Oxyphenisatine

C20H15NO3 (317.105188)


CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3927; ORIGINAL_PRECURSOR_SCAN_NO 3925 A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3937; ORIGINAL_PRECURSOR_SCAN_NO 3935 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3903; ORIGINAL_PRECURSOR_SCAN_NO 3901 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3930; ORIGINAL_PRECURSOR_SCAN_NO 3928 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3916; ORIGINAL_PRECURSOR_SCAN_NO 3914 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3917; ORIGINAL_PRECURSOR_SCAN_NO 3916 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7947; ORIGINAL_PRECURSOR_SCAN_NO 7945 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7982; ORIGINAL_PRECURSOR_SCAN_NO 7981 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7987; ORIGINAL_PRECURSOR_SCAN_NO 7982 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8022; ORIGINAL_PRECURSOR_SCAN_NO 8020 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8036; ORIGINAL_PRECURSOR_SCAN_NO 8034 CONFIDENCE standard compound; INTERNAL_ID 625; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8042; ORIGINAL_PRECURSOR_SCAN_NO 8039

   

3,N4-Benzoquinone-deoxycytodine

3,N4-Benzoquinone-deoxycytodine

C15H15N3O5 (317.101166)


   
   

3-O-Methylrimiterol sulfate

3-O-Methylrimiterol sulfate

C13H19NO6S (317.0933034)


   

5,4-Dimethyl-6-hydroxyluteolinidin

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025082)


   

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-2-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.10274300000003)


   

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

C13H19NO8 (317.1110614)


   

Synephrine tartrate

Synephrine tartrate

C13H19NO8 (317.1110614)


   

Metaraminol bitartrate

Metaraminol bitartrate

C13H19NO8 (317.1110614)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

Imipenem

Imipenem hydrate

C12H19N3O5S (317.10453640000003)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

1-(4-(4-Nitro-3-(trifluoromethyl)phenyl)piperazin-1-yl)ethanone

C13H14F3N3O3 (317.09872100000007)


   

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

2-quinolin-4-yl-1-[4-(trifluoromethyl)phenyl]ethanol

C18H14F3NO (317.10274300000003)


   

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.10633079999997)


   

Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate

Methyl 4-(4-(Bis(2-Chloroethyl)Amino)Phenyl)Butyrate

C15H21Cl2NO2 (317.0949266)


   

N-Dipropyldopamine hydrobromide

N-Dipropyldopamine hydrobromide

C14H24BrNO2 (317.0990304)


   
   

Phenylephrine tartrate

(-)-Phenylephrine hydrogentartrate

C13H19NO8 (317.1110614)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1-benzhydrylazetidin-3-yl Methanesulfonate

1-benzhydrylazetidin-3-yl Methanesulfonate

C17H19NO3S (317.1085584)


   

RS 127445

RS 127445

C17H17ClFN3 (317.1094964)


RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites[1].

   

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

C17H16FNO4 (317.10633079999997)


   

tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

tert-butyl 4-[4-(chloromethyl)-1,3-thiazol-2-yl]piperazine-1-carboxylate

C13H20ClN3O2S (317.096469)


   
   

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

4-[(2-Biphenylylcarbonyl)amino]benzoic acid

C20H15NO3 (317.105188)


   
   

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

C14H17F2NO5 (317.1074736)


   

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

4,4,5,5-Tetramethyl-2-(2-nitro-5-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane

C13H15BF3NO4 (317.1046176)


   

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

2-QUINOLIN-2-YL-1-(3-TRIFLUROMETHYLPHENYL)ETHANOL

C18H14F3NO (317.10274300000003)


   

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride

6-methoxy-N-(4-methoxyphenyl)quinazolin-4-amine,hydrochloride

C16H16ClN3O2 (317.09309859999996)


   

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

C17H19NO3S (317.1085584)


   

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

2-(2-Deoxy-beta-D-erythro-pentofuranosyl)-7-hydroxypyrimido(1,6-a)benzimidazol-1(2H)-one

C15H15N3O5 (317.101166)


   

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

3-Carbamoyl-5-(4-phenylphenyl)benzoic acid

C20H15NO3 (317.105188)


   

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[2-(methylamino)ethyl]-2-sulfanylidenepyrimidin-4-one

C12H19N3O5S (317.10453640000003)


   

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

1-[4-[2-Nitro-4-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone

C13H14F3N3O3 (317.09872100000007)


   

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C17H19NO3S (317.1085584)


   

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

2-[[1-(4-Chlorophenyl)-4-pyrazolo[3,4-d]pyrimidinyl]amino]-1-butanol

C15H16ClN5O (317.10433159999997)


   

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

1-(4-chlorophenyl)-N-(1-methoxypropan-2-yl)-4-pyrazolo[3,4-d]pyrimidinamine

C15H16ClN5O (317.10433159999997)


   

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

2-[[2-furanyl(oxo)methyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

C15H15N3O5 (317.101166)


   

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

C13H19NO8 (317.1110614)


   

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

N-(furan-2-ylmethyl)-N-[(Z)-(2-hydroxy-3-methoxyphenyl)methylideneamino]oxamide

C15H15N3O5 (317.101166)


   

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

(8E)-8-[(2-fluoroanilino)hydrazinylidene]-1,3-dimethylpurine-2,6-dione

C13H12FN7O2 (317.1036464)


   

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

N-[2-[(2Z)-2-[(2-hydroxy-3-methoxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]furan-2-carboxamide

C15H15N3O5 (317.101166)


   

Oxyphenisatine

Oxyphenisatine

C20H15NO3 (317.105188)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation > A06AB - Contact laxatives C78276 - Agent Affecting Digestive System or Metabolism > C29697 - Laxative D005765 - Gastrointestinal Agents > D002400 - Cathartics

   
   

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

6,7,3-Trihydroxy-5,4-dimethoxy-flavylium

C17H17O6+ (317.1025082)


   

LY456236

LY456236

C16H16ClN3O2 (317.09309859999996)


LY456236 is a selective, non-competitive and orally active mGlu1 receptor antagonist that inhibits phosphoinositide hydrolysis with an IC50 of 0.145 μM. LY456236 also inhibits EGFR with an IC50 of 0.91 μM[1][3].

   

5,4'-Dimethyl-6-hydroxyluteolinidin

5,4'-Dimethyl-6-hydroxyluteolinidin

C17H17O6 (317.1025082)


   

9-hydroxy-7-methoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

9-hydroxy-7-methoxy-13-methyl-10-azapentacyclo[9.7.1.0²,¹⁰.0³,⁸.0¹⁵,¹⁹]nonadeca-1,3(8),4,6,11,13,15(19),16-octaen-18-one

C20H15NO3 (317.105188)


   

8-(1h-indol-3-yl)-2-methoxy-6-methylnaphthalene-1,4-dione

8-(1h-indol-3-yl)-2-methoxy-6-methylnaphthalene-1,4-dione

C20H15NO3 (317.105188)


   

(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

(4ar,7s)-6,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-5-methoxy-4a,7-dihydro-1λ⁴-chromen-1-ylium

[C17H17O6]+ (317.1025082)


   

acalyphine

NA

C13H19NO8 (317.1110614)


{"Ingredient_id": "HBIN014320","Ingredient_name": "acalyphine","Alias": "NA","Ingredient_formula": "C13H19NO8","Ingredient_Smile": "CN1C=C(C(=CC1=O)OC)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23592","TCMSP_id": "NA","TCM_ID_id": "7249","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1110614)


   

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1110614)


   

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

(2s)-4-(c-hydroxycarbonimidoyl)-2-[(3-hydroxyquinolin-2-yl)formamido]butanoic acid

C15H15N3O5 (317.101166)